SMO and meningioma: Subsequent analysis of their genomic landscape revealed one type (type A) was composed of only benign meningiomas with mutations in TRAF7, AKT1, KLF4, SMO. The other two types had chr22q/NF2 loss (type B and C) but no other known mutations.